Correlation Between GlucoTrack and Ekso Bionics

Can any of the company-specific risk be diversified away by investing in both GlucoTrack and Ekso Bionics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlucoTrack and Ekso Bionics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between GlucoTrack and Ekso Bionics Holdings, you can compare the effects of market volatilities on GlucoTrack and Ekso Bionics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlucoTrack with a short position of Ekso Bionics. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlucoTrack and Ekso Bionics.

Diversification Opportunities for GlucoTrack and Ekso Bionics

0.61

Correlation Coefficient

GlucoTrack  Ekso Bionics

Poor diversification

The 3 months correlation between GlucoTrack and Ekso is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding GlucoTrack and Ekso Bionics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ekso Bionics Holdings and GlucoTrack is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlucoTrack are associated (or correlated) with Ekso Bionics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ekso Bionics Holdings has no effect on the direction of GlucoTrack i.e., GlucoTrack and Ekso Bionics go up and down completely randomly.

Pair Corralation between GlucoTrack and Ekso Bionics

Given the investment horizon of 90 days GlucoTrack is expected to under-perform the Ekso Bionics. In addition to that, GlucoTrack is 2.19 times more volatile than Ekso Bionics Holdings. It trades about -0.33 of its total potential returns per unit of risk. Ekso Bionics Holdings is currently generating about -0.06 per unit of volatility. If you would invest  61.00  in Ekso Bionics Holdings on December 29, 2024 and sell it today you would lose (17.00) from holding Ekso Bionics Holdings or give up 27.87% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

GlucoTrack  vs.  Ekso Bionics Holdings

GlucoTrack

Risk-Adjusted Performance

Very Weak

Over the last 90 days GlucoTrack has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in April 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Ekso Bionics Holdings

Risk-Adjusted Performance

Very Weak

Over the last 90 days Ekso Bionics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with GlucoTrack and Ekso Bionics

The main advantage of trading using opposite GlucoTrack and Ekso Bionics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlucoTrack position performs unexpectedly, Ekso Bionics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ekso Bionics will offset losses from the drop in Ekso Bionics' long position.

The idea behind GlucoTrack and Ekso Bionics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.